Concentrix Co. (NASDAQ:CNXC – Get Free Report) EVP Cormac J. Twomey sold 500 shares of Concentrix stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $55.60, for a total value of $27,800.00. Following the completion of the sale, the executive vice president now directly owns 41,111 shares in the company, valued at approximately $2,285,771.60. This represents a 1.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Concentrix Price Performance
NASDAQ:CNXC opened at $52.28 on Friday. The stock has a market capitalization of $3.37 billion, a PE ratio of 14.09, a P/E/G ratio of 0.75 and a beta of 0.63. Concentrix Co. has a 1-year low of $36.28 and a 1-year high of $91.20. The firm has a fifty day simple moving average of $46.07 and a 200 day simple moving average of $53.82. The company has a current ratio of 1.42, a quick ratio of 1.57 and a debt-to-equity ratio of 1.17.
Concentrix (NASDAQ:CNXC – Get Free Report) last posted its quarterly earnings results on Wednesday, January 15th. The company reported $3.26 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.25. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The business had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same quarter last year, the company posted $3.36 earnings per share. Concentrix’s quarterly revenue was up 9.7% on a year-over-year basis. On average, research analysts expect that Concentrix Co. will post 10.11 EPS for the current fiscal year.
Concentrix Cuts Dividend
Hedge Funds Weigh In On Concentrix
Large investors have recently modified their holdings of the stock. State Street Corp grew its stake in Concentrix by 1.3% in the 3rd quarter. State Street Corp now owns 1,401,953 shares of the company’s stock valued at $71,850,000 after buying an additional 18,304 shares during the last quarter. Copeland Capital Management LLC grew its position in shares of Concentrix by 32.9% in the fourth quarter. Copeland Capital Management LLC now owns 1,333,206 shares of the company’s stock valued at $57,688,000 after purchasing an additional 329,831 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Concentrix by 5.2% during the third quarter. Geode Capital Management LLC now owns 878,092 shares of the company’s stock worth $45,013,000 after purchasing an additional 43,295 shares during the period. Invenomic Capital Management LP lifted its holdings in Concentrix by 354.3% during the 3rd quarter. Invenomic Capital Management LP now owns 472,243 shares of the company’s stock worth $24,202,000 after purchasing an additional 368,295 shares during the last quarter. Finally, Loomis Sayles & Co. L P boosted its stake in Concentrix by 8.1% in the 3rd quarter. Loomis Sayles & Co. L P now owns 305,492 shares of the company’s stock valued at $15,657,000 after purchasing an additional 22,815 shares during the period. 90.34% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group lowered their price objective on shares of Concentrix from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $75.00.
Check Out Our Latest Research Report on CNXC
About Concentrix
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Further Reading
- Five stocks we like better than Concentrix
- Dividend Capture Strategy: What You Need to Know
- Nebius Group: Market Overreaction or Real AI Disruption?
- CD Calculator: Certificate of Deposit Calculator
- The Best Way to Invest in Gold Is…
- How to Most Effectively Use the MarketBeat Earnings Screener
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.